Citius Oncology Inc (CTOR) Stock Price, Quote & News

Company Profile

Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: (908) 967-6677

Address:

11 Commerce Drive, First Floor, Cranford, United States

Awe007 Dec. 5 at 2:49 AM

$CTXR $CTOR

0 · Reply

yellowjacker Dec. 5 at 12:28 AM

Would be interesting to know what a BO would look like for $CTXR and $CTOR if Lymphir would take off. I worry about the inter-relationship of the two companies and the other products that $CTXR owns.

0 · Reply

SweStonk Dec. 4 at 10:32 PM

$CTOR The lifeboat is also sinking! Jeeeez. Mazur have accomplished to destroy not only one company but two. Where ever he goes disaster follows

0 · Reply

jointheflow Dec. 4 at 5:03 PM

$CTOR more sales, more money will come in.

0 · Reply

Awe007 Dec. 4 at 3:53 PM

$CTOR

0 · Reply

donein12 Dec. 4 at 2:23 PM

$CTOR Distributor's is good to hear,however only an announcement of contracts for sales will move CTOR significantly higher. Apparently there was an expectation of news that assumed sales is the reason it ran up 20% early in PM and when the news announced was about distributors the disapointment brought the price down significantly.

0 · Reply

NetworkNewsWire Dec. 4 at 2:18 PM

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations $SNGX $AMGN $FOLD $CTOR $TNXP https://ibn.fm/GbzxS

0 · Reply

JohnTrack Dec. 4 at 1:52 PM

$CTOR fresh mention on this name... https://www.rapidticker.com/news/ctor-citius-oncology-expands-lymphir-distribution-ffcf33

0 · Reply

Rybod30 Dec. 4 at 1:49 PM

$CTOR Private placement from 3 months ago says undervalued along with recent PRs, but🤷‍♂️😬…

0 · Reply

Awe007 Dec. 4 at 1:45 PM

$CTOR will she wake up?? More markets = more revenue

0 · Reply

Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim

CTXR

Dec 1, 2025, 12:00 PM EST - 3 days ago

Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)

CTXR

Nov 25, 2025, 8:00 AM EST - 10 days ago

Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting

CTXR

Nov 21, 2025, 8:37 AM EST - 14 days ago

Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration

CTXR

Oct 20, 2025, 8:37 AM EDT - 6 weeks ago

Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch

Oct 17, 2025, 5:00 PM EDT - 6 weeks ago

Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences

CTXR

Oct 16, 2025, 8:47 AM EDT - 7 weeks ago

Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™

CTXR

Oct 7, 2025, 8:47 AM EDT - 2 months ago

Citius Oncology Establishes International Access to LYMPHIR™ via Named Patient Programs in Southern Europe

Sep 10, 2025, 4:30 PM EDT - 3 months ago

Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement

CTXR

Sep 9, 2025, 8:30 AM EDT - 3 months ago

Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement

CTXR

Aug 22, 2025, 8:47 AM EDT - 3 months ago

Citius Oncology Deploys AI Platform to Amplify the Performance of its Commercial Team Ahead of LYMPHIR Launch

CTXR

Aug 12, 2025, 4:30 PM EDT - 4 months ago

Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update

Jul 17, 2025, 4:30 PM EDT - 5 months ago

Citius Oncology Announces Closing of $9.0 Million Public Offering

CTXR

Jul 16, 2025, 9:15 AM EDT - 5 months ago

Citius Oncology Announces Pricing of $9.0 Million Public Offering

CTXR

Jul 15, 2025, 8:32 AM EDT - 5 months ago

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora

CTXR

Jun 17, 2025, 8:08 AM EDT - 6 months ago

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025

CTXR

May 14, 2025, 4:30 PM EDT - 7 months ago

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update

May 5, 2025, 8:37 AM EDT - 7 months ago

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

CTXR

Feb 14, 2025, 4:30 PM EST - 10 months ago

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

CTXR

Feb 14, 2025, 4:30 PM EST - 10 months ago

Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Feb 6, 2025, 8:55 AM EST - 10 months ago

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

CTXR

Jan 7, 2025, 8:08 AM EST - 11 months ago

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

CTXR

Jan 6, 2025, 7:50 AM EST - 11 months ago

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

CTXR

Dec 27, 2024, 5:00 PM EST - 1 year ago

Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

Awe007 Dec. 5 at 2:49 AM

$CTXR $CTOR

0 · Reply

yellowjacker Dec. 5 at 12:28 AM

Would be interesting to know what a BO would look like for $CTXR and $CTOR if Lymphir would take off. I worry about the inter-relationship of the two companies and the other products that $CTXR owns.

0 · Reply

SweStonk Dec. 4 at 10:32 PM

$CTOR The lifeboat is also sinking! Jeeeez. Mazur have accomplished to destroy not only one company but two. Where ever he goes disaster follows

0 · Reply

jointheflow Dec. 4 at 5:03 PM

$CTOR more sales, more money will come in.

0 · Reply

Awe007 Dec. 4 at 3:53 PM

$CTOR

0 · Reply

donein12 Dec. 4 at 2:23 PM

0 · Reply

NetworkNewsWire Dec. 4 at 2:18 PM

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations $SNGX $AMGN $FOLD $CTOR $TNXP https://ibn.fm/GbzxS

0 · Reply

JohnTrack Dec. 4 at 1:52 PM

$CTOR fresh mention on this name... https://www.rapidticker.com/news/ctor-citius-oncology-expands-lymphir-distribution-ffcf33

0 · Reply

Rybod30 Dec. 4 at 1:49 PM

$CTOR Private placement from 3 months ago says undervalued along with recent PRs, but🤷‍♂️😬…

0 · Reply

Awe007 Dec. 4 at 1:45 PM

$CTOR will she wake up?? More markets = more revenue

0 · Reply

TwongStocks Dec. 4 at 1:37 PM

$CTOR $CTXR Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim https://www.prnewswire.com/news-releases/citius-oncology-expands-lymphir-distribution-to-turkey-and-middle-east-countries-through-exclusive-agreement-with-er-kim-302632064.html • Partnership expands access to LYMPHIR for patients with cutaneous T-cell lymphoma across Turkey, Bahrain, Qatar, Oman, Kuwait, Saudi Arabia, and the UAE • LYMPHIR international availability extends to 19 markets outside the U.S.

2 · Reply

The_Stock_Profit Dec. 4 at 1:22 PM

$CTOR easy short on the pumpers 😊😊

0 · Reply

TwongStocks Dec. 4 at 1:18 PM

$CTOR lots of volume premarket on CTOR today. Looks like some paid promos on X right around 8am ET. The X posts include link to the paid disclaimers. I don't see similar activity on $CTXR yet.

1 · Reply

Awe007 Dec. 4 at 1:15 PM

$CTOR so, uh what was that half a million volumn in 5 minutes?? lol

0 · Reply

SweStonk Dec. 4 at 1:11 PM

$CTOR still overvalued

1 · Reply

FishFace09 Dec. 4 at 1:10 PM

$CTOR BTMFD

0 · Reply

AlertsAndNews Dec. 4 at 1:07 PM

Good morning. Gappers this morning include $PLRZ $KALA $MKZR $PMI $CTOR Lets get it

0 · Reply

DaBullRunner Dec. 4 at 1:06 PM

$CTOR there it goes … 🚨EPOW🚨 just received a $30M contract That is HUGE for a tiny company This should be at least $2 🎯✅ I’m even willing to put some of my TSLA COIN profits into EPOW👇💰💰💰

0 · Reply

Awe007 Dec. 4 at 1:04 PM

$CTOR boom

1 · Reply

RHEMVS Dec. 4 at 2:15 AM

$CTOR That had all the excitement of a wet fart in a cafeteria line.

1 · Reply

ppl_first Dec. 4 at 1:13 AM

$CTOR is not going up on good news because the market already threw the party weeks ago. Launch headlines were expected, not surprising. Fresh supply is everywhere: recent offerings, warrants, RSUs, options, and a shelf registration hanging overhead like a vending machine of new shares. Every pop becomes a way for more shares to enter the market. No hard revenue yet, no guidance fireworks, just narrative horseshit. The product launched, but the stock is still in cash-register mode. Hope for the best.

0 · Reply

whathappenedtomyaccount Dec. 3 at 4:51 PM

$CTOR someone told lenny that shareholders in ctxr/ctor had lost some 95% of their value. lenny, never satisfied, said job's not finished until 99.999%

0 · Reply

Market Cap	108.57M
Revenue (ttm)	0.00
Net Income (ttm)	-21.15M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.35

Volume	2,113,400
Avg Vol	389,296
Day's Range	N/A - N/A
Shares Out	83.51M
Stochastic %K	5%
Beta	2.98
Analysts	Strong Sell
Price Target	$6.00